Skip to main content
Premium Trial:

Request an Annual Quote

Quintiles, London Genetics Ink PGx Services Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Quintiles and London Genetics have struck a partnership to provide biomarker and pharmacogenomics consulting and services to biopharmaceutical firms, Research Triangle Park, NC-based Quintiles said today.

The two companies will collaborate to provide pharmacogenetic solutions, including novel biomarker and assay development services.

"Ultimately, our alliance will support biopharma in their interactions with academic partners and the development of personalized medicines," London Genetics CEO Dominique Kleyn said in a statement.

Among the services provided by Quintiles are biomarker tests that analyze genes and proteins that affect cell growth and mutation.

London Genetics helps companies to apply genetic knowledge that can take risk out of clinical trials. It also designs and manages projects and patient cohorts through partnerships with relevant academics and clinicians.

Thomas Wollman, senior VP of Quintiles Global Central Laboratories, said that the two firms have "expertise to help early adopters of personalized medicine use genomic technologies to improve drug discovery and development, and a networked infrastructure to support those efforts virtually anywhere in the world."

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.